BioVaxys Technology Corp.
BioVaxys Technology Corp.
Indice CSE:
CSE CompositeDevise:
CAD BioVaxys Technology Corp. is a British Columbia-registered biopharmaceuticals company based in Ontario, Canada that is developing BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© 'neoantigen' tumor cell construct platform for treating refractive late stage ovarian cancer. BioVaxys is also exploring vaccines for additional cancers and infectious diseases based on its HapTenix©platform through academic and other collaborations.
BioVaxys Technology Corp. (BIOV)
0.05
0.00 (0.00%)
BioVaxys Technology Corp. (BIOV)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Quantité demandé
39,000
Cours acheteur
0.05
Cours vendeur
0.055
Quantité offerte
2,000
Volume
13,500
Dernier prix
0.05
Écart minimum
variation nette
Clôture précédente
0.05
Ouverture
0.05
Day High
0.05
Day Low
0.05
Haut 52 semaines
0.09
Bas 52 semaines
0.04
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
20,000
Cours acheteur
0.04
Cours vendeur
0.00
Quantité offerte
0
Volume
0
Dernier prix
0.045
Écart minimum
variation nette
Clôture précédente
0.045
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
39,000
Cours acheteur
0.05
Cours vendeur
0.055
Quantité offerte
2,000
Volume
13,500
Dernier prix
0.05
Écart minimum
variation nette
Clôture précédente
0.05
Ouverture
0.05
Day High
0.05
Day Low
0.05
Haut 52 semaines
0.09
Bas 52 semaines
0.04
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
20,000
Cours acheteur
0.04
Cours vendeur
0.00
Quantité offerte
0
Volume
0
Dernier prix
0.045
Écart minimum
variation nette
Clôture précédente
0.045
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| National Bank Financial Inc. | 1,000 | 0.05 | 0.055 | 2,000 | National Bank Financial Inc. |
| TD Securities Inc. | 32,000 | 0.05 | 0.06 | 70,000 | Anonymous |
| TD Securities Inc. | 6,000 | 0.05 | 0.06 | 80,000 | Anonymous |
| CIBC World Markets Inc. | 50,000 | 0.045 | 0.06 | 10,000 | TD Securities Inc. |
| CIBC World Markets Inc. | 100,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| National Bank Financial Inc. | 11,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| TD Securities Inc. | 20,000 | 0.045 | 0.06 | 1,000 | National Bank Financial Inc. |
| CIBC World Markets Inc. | 11,000 | 0.045 | 0.06 | 26,000 | National Bank Financial Inc. |
| Merrill Lynch Canada Inc. | 3,000 | 0.045 | 0.06 | 5,000 | Scotia Capital Inc. |
| CIBC World Markets Inc. | 15,000 | 0.04 | 0.06 | 33,000 | Merrill Lynch Canada Inc. |
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| Anonymous | 20,000 | 0.04 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 3 | 39,000 | 0.05 | 0.055 | 2,000 | 1 |
| 6 | 195,000 | 0.045 | 0.06 | 287,000 | 10 |
| 9 | 232,000 | 0.04 | 0.065 | 152,000 | 15 |
| 6 | 106,000 | 0.035 | 0.07 | 298,000 | 8 |
| 2 | 75,000 | 0.03 | 0.075 | 2,105,000 | 5 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 1 | 20,000 | 0.04 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
|---|---|---|---|---|---|---|
| Mar 14, 17:22 | 0.05 | 0.00 | 9,000 | W.D. Latimer Co. Limited | TD Securities Inc. | CSE |
| Mar 14, 17:22 | 0.05 | 0.00 | 1,000 | National Bank Financial Inc. | TD Securities Inc. | CSE |
| Mar 14, 14:33 | 0.05 | 0.00 | 1,000 | W.D. Latimer Co. Limited | National Bank Financial Inc. | CSE |
| Mar 14, 14:00 | 0.05 | 0.00 | 2,000 | Merrill Lynch Canada Inc. | National Bank Financial Inc. | CSE |
| Mar 13, 18:27 | 0.05 | 0.00 | 10,000 | RBC Capital Markets | Anonymous | CSE |
Information d'entreprise
Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
CanadaTéléphone
646-452-7000Courriel
jpassin@biovaxys.comURL
https://biovaxys.com/Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust CompanyCourriel
news@biovaxys.comVérificateur
Dale Matheson Carr-Hilton Labonte LLPSEDAR Information
Type de dossier
Tout
News Releases
Material Change Report
Management's Discussion & Analysis
Financial Statements
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
CanadaTéléphone
646-452-7000Courriel
jpassin@biovaxys.comURL
https://biovaxys.com/Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust CompanyCourriel
news@biovaxys.comVérificateur
Dale Matheson Carr-Hilton Labonte LLPCapitalisation
Capitalisation:
291525203Réservé à l'émission:
139701394Company Officers
James Passin, CEO
Kenneth Kovan, COO & President
Christopher Cherry, Chief Financial Officer
James Passin, Chief Executive Officer
Christopher Cherry, Chief Financial Officer
Kenneth Kovan, Chief Operating Officer and President
Dépôts CSE
